Background: Stroke is a major cause of mortality and long term disability in adults. TRPV1 has a pivotal role in neuroinflammation. Among TLRs, TLR2 significantly participate in induction of inflammation in brain. In this study, the effect of TRPV1 receptor agonist and antagonist on outcome and gene expression of TLR2 in a rat model of permanent middle cerebral artery occlusion (MCAO) was investigated.Methods: Forty male rats were assigned to the following groups: sham, vehicle )stroke), AMG9810 (selective TRPV1 antagonist, 0.5 mg/kg; 3 h after stroke), and capsaicin (1 mg/kg; 3 h after stroke). Stroke was induced by permanent middle cerebral artery occlusion and behavioral functions were assessed 1, 3, and 7 days after stroke. Infarct volu...
Background/Aims: In response to experimental stroke, a characteristic functional and expressional up...
OBJECTIVE: Ischemic stroke may result from transient or permanent reductions of regional cerebral bl...
Ischemic stroke is known to be one of the leading causes of death worldwide. As therapeutic options ...
Background: Stroke is a major cause of mortality and long term disability in adults. TRPV1 has a piv...
Objective: Ischemic stroke is a major cause of death and prolonged disability worldwide. Inflammatio...
A significant up-regulation of Toll-like-receptor (TLR) mRNAs between 3 and 48 h reperfusion time af...
A significant up-regulation of Toll-like-receptor (TLR) mRNAs between 3 and 48 h reperfusion time af...
Recent studies have shown that Toll-like receptors (TLRs) are involved in cerebral ischemia/reperfus...
Background and Purpose Ischaemic stroke is a leading cause of death, disability, and a high unmet me...
Abstract Background Using a live imaging approach, we have previously shown that microglia activatio...
Toll-like receptors (TLRs), a class of pattern recognition proteins, play an integral role in the mo...
Transient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel with high Ca²⁺ pe...
<p>Blood–brain barrier (BBB) disruption and subsequent brain edema play important roles in the secon...
Triggering receptor expressed on myeloid cells-2 (TREM2) is a microglial surface receptor involved i...
<p>Blood–brain barrier (BBB) disruption and subsequent brain edema play important roles in the secon...
Background/Aims: In response to experimental stroke, a characteristic functional and expressional up...
OBJECTIVE: Ischemic stroke may result from transient or permanent reductions of regional cerebral bl...
Ischemic stroke is known to be one of the leading causes of death worldwide. As therapeutic options ...
Background: Stroke is a major cause of mortality and long term disability in adults. TRPV1 has a piv...
Objective: Ischemic stroke is a major cause of death and prolonged disability worldwide. Inflammatio...
A significant up-regulation of Toll-like-receptor (TLR) mRNAs between 3 and 48 h reperfusion time af...
A significant up-regulation of Toll-like-receptor (TLR) mRNAs between 3 and 48 h reperfusion time af...
Recent studies have shown that Toll-like receptors (TLRs) are involved in cerebral ischemia/reperfus...
Background and Purpose Ischaemic stroke is a leading cause of death, disability, and a high unmet me...
Abstract Background Using a live imaging approach, we have previously shown that microglia activatio...
Toll-like receptors (TLRs), a class of pattern recognition proteins, play an integral role in the mo...
Transient receptor potential vanilloid 1 (TRPV1) is a non-selective cation channel with high Ca²⁺ pe...
<p>Blood–brain barrier (BBB) disruption and subsequent brain edema play important roles in the secon...
Triggering receptor expressed on myeloid cells-2 (TREM2) is a microglial surface receptor involved i...
<p>Blood–brain barrier (BBB) disruption and subsequent brain edema play important roles in the secon...
Background/Aims: In response to experimental stroke, a characteristic functional and expressional up...
OBJECTIVE: Ischemic stroke may result from transient or permanent reductions of regional cerebral bl...
Ischemic stroke is known to be one of the leading causes of death worldwide. As therapeutic options ...